![Marco Londei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marco Londei
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Marco Londei
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Imperial College London
327
| College/University | Other Consumer Services | 327 |
University College London
90
| College/University | Other Consumer Services | 90 |
Public Company | Pharmaceuticals: Major | 37 | |
Public Company | Biotechnology | 23 | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marco Londei tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
MANNKIND CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Chairman Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Institute of Cancer Research: Royal Cancer Hospital
![]() The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member | |
Raine Ventures LLC
![]() Raine Ventures LLC Investment ManagersFinance Raine Ventures LLC (Raine Ventures) is a venture capital firm, a subsidiary of The Raine Group LLC founded in 2010 by Brandon Gardner, Deborah Mei, Joseph Ravitch, John Salter, and Jeff Sine. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
University of Oxford | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
School of Oriental & African Studies | College/University | Graduate Degree Graduate Degree | |
University of Cambridge | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Inflexion Private Equity Partners LLP
![]() Inflexion Private Equity Partners LLP Investment ManagersFinance Inflexion Private Equity Partners LLP (Inflexion Private Equity Partners) is a private equity firm founded in 1999 by John Frederick Hartz and Simon Eric Hugh Turner. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Graduate Degree Masters Business Admin | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Mobeus Equity Partners LLP
![]() Mobeus Equity Partners LLP Investment ManagersFinance Mobeus Equity Partners LLP (Mobeus Equity Partners) is an independent private equity firm founded in 2012. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
New York University | College/University | Graduate Degree Graduate Degree | |
University of Arizona | College/University | Undergraduate Degree Graduate Degree | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Instituto de Empresa SL | College/University | Graduate Degree | |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Private Equity Investor | |
London Business School | College/University | Undergraduate Degree Masters Business Admin | |
National Academy of Medicine (United States)
![]() National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The J. David Gladstone Institutes
![]() The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services The J. David Gladstone Institutes operates as an independent state-of-the-art biomedical research institution. The company was founded in 1979 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
King's College London | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
The Engineering & Physical Sciences Research Council
![]() The Engineering & Physical Sciences Research Council Miscellaneous Commercial ServicesCommercial Services The Engineering & Physical Sciences Research Council provides funds for research and training in engineering and the physical sciences. It covers range of subjects from mathematics to material science and from information technology to structural engineering. The firm offers services to the users and beneficiaries of chemical, communications, construction, electrical, electronic, energy, engineering, information technology, pharmaceutical, process and other industries. The company was founded in 1994 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SPI Investments LLC (Michigan) | Director/Board Member | ||
Syncona Partners LLP
![]() Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Duke University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Bourn Bioscience Ltd.
![]() Bourn Bioscience Ltd. Medical/Nursing ServicesHealth Services Bourn Bioscience Ltd. is a holding company, which engages in the supply of fertility services. The company was founded in June 15, 2005 and is headquartered in Cambridge, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Chairman | |
The Boston Consulting Group | Consultant / Advisor Consultant / Advisor | ||
Lakestar Advisors UK LLP | Investment Managers | Private Equity Investor | |
HQI Holdings Ltd.
![]() HQI Holdings Ltd. Financial ConglomeratesFinance HQI Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member | |
Hqi Ltd.
![]() Hqi Ltd. Miscellaneous Commercial ServicesCommercial Services Hqi Ltd. provides management consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Ara Darzi Qatar Ltd. | Director/Board Member | ||
Sqi Ltd.
![]() Sqi Ltd. Specialty StoresRetail Trade Sqi Ltd. is a private company headquartered in Dublin, Ireland, that engages in retail sale. | Specialty Stores | Director/Board Member | |
World Innovation Summit For Health | Chairman | ||
Jiangxi Keyuan Bio-Material Co., Ltd.
![]() Jiangxi Keyuan Bio-Material Co., Ltd. Chemicals: SpecialtyProcess Industries Part of Legend Holdings Corp., Jiangxi Keyuan Bio-Material Co., Ltd. is a Chinese company that manufactures and sells polymerized lactic acid and related products. The company is based in Jiujiang, China. The company was founded in 2008. De Ye Chen has been the CEO of the company since 2020. Jiangxi Keyuan Bio-Material Co. was acquired by Levima Advanced Materials Corp. on September 30, 2021 for $4.41 million. | Chemicals: Specialty | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 29 |
Regno Unito | 15 |
Qatar | 3 |
Francia | 2 |
Spagna | 2 |
Settori
Consumer Services | 16 |
Health Technology | 12 |
Finance | 10 |
Commercial Services | 8 |
Consumer Non-Durables | 2 |
Posizioni
Director/Board Member | 412 |
Corporate Officer/Principal | 190 |
Independent Dir/Board Member | 133 |
Undergraduate Degree | 81 |
Graduate Degree | 61 |
Contatti più connessi
Insiders | |
---|---|
Carol Gallagher | 39 |
Carol Bell | 39 |
Dinesh C. Paliwal | 31 |
Dennis Fenton | 28 |
Rachel Janis Lomax | 27 |
John Schmid | 24 |
Azeeza Aziz Khan | 24 |
Charles Sigal | 20 |
Robert Williams | 20 |
Thomas Lynch | 20 |
Brian Daniels | 20 |
Jonathan Leslie Tobin | 19 |
Ahmad Mustapha bin Ghazali | 18 |
Muaz bin Jema Anton Khan | 18 |
Lord Darzi | 18 |
- Borsa valori
- Insiders
- Marco Londei
- Connessioni Società